Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

NCT03967249 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: IONIS GHR-LRx
DRUG: Somatostatin Receptor Ligand (SRL)

Sponsor

Ionis Pharmaceuticals, Inc.